1. Introduction

Marine Drugs

1660-3397

Molecular Diversity Preservation International

10.3390/md9091580

marinedrugs-09-01580

Review

Recently Confirmed Apoptosis-Inducing Lead Compounds Isolated from Marine Sponge of Potential Relevance in Cancer Treatment

Essack

Magbubah

Bajic

Vladimir B.

Archer

John A.C.

* Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, Jeddah 23955-6900, Kingdom of Saudi Arabia; E-Mails: magbubah.essack@kaust.edu.sa (M.E.); vladimir.bajic@kaust.edu.sa (V.B.B.)

* Author to whom correspondence should be addressed; E-Mail: john.archer@kaust.edu.sa; Tel.: +966-544-700-701; Fax: +966-(2)-802-0127.

2011

20 9 2011

9 9 1580 1606 6 8 2011 31 8 2011 7 9 2011

2011

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Despite intense efforts to develop non-cytotoxic anticancer treatments, effective agents are still not available. Therefore, novel apoptosis-inducing drug leads that may be developed into effective targeted cancer therapies are of interest to the cancer research community. Targeted cancer therapies affect specific aberrant apoptotic pathways that characterize different cancer types and, for this reason, it is a more desirable type of therapy than chemotherapy or radiotherapy, as it is less harmful to normal cells. In this regard, marine sponge derived metabolites that induce apoptosis continue to be a promising source of new drug leads for cancer treatments. A PubMed query from 01/01/2005 to 31/01/2011 combined with hand-curation of the retrieved articles allowed for the identification of 39 recently confirmed apoptosis-inducing anticancer lead compounds isolated from the marine sponge that are selectively discussed in this review.

marine sponge apoptosis cancer treatment targeted cancer therapy anticancer

1. Introduction

Conventional anticancer treatment such as ionizing radiation, hyperthermia, alkylating agents, DNA topoisomerase inhibitors, and platinum compounds induce DNA damage indiscriminately, thus killing the normal cell and the rapidly proliferating cancer cell. Since these drugs are not specifically selective for cancer cells, cancer patients suffer from adverse side effects [1]. These cytotoxic anticancer treatments are being supplemented by targeted therapies that recognize specific targets for cancer cell to improve efficacy of treatment and reduce side effects. Targeted therapies include apoptosis-inducers, angiogenesis inhibitors, signal-transduction inhibitors, monoclonal antibodies and gene therapy [2]. Apoptosis-inducers in particular can be used to induce cell death via the genes and proteins that control apoptosis, since tumor-specific alterations in apoptotic programs provide opportunities to target cell death in a selective manner [3]. Using these genes and proteins as potential drug targets, the apoptosis-inducers that directly induce apoptosis may provide less opportunity for acquired drug resistance, decrease mutagenesis and reduce toxicity. It is for these reasons that we have a general interest in identifying compounds that possess apoptosis-inducing capabilities. In the last decade numerous apoptosis-inducers have been isolated from marine sponges.

Marine sponges, Phylum Porifera, are the most primitive of the multicellular organisms comprising approximately 15,000 sponge species [4]. Sponges are primarily filter feeders as most rely on water constantly circulating through their porous bodies from which they filter out microorganisms and organic particles as a food source, others rely on endosymbionts to produce food and oxygen [5], while others have also been identified as carnivores that feed mainly on small crustaceans [6]. Sponges, and/or their symbionts, produce a plethora of secondary metabolites to repel and deter predators [7,8] and to compete for space with other sessile marine organisms [9]. Sponges are acknowledged as the most versatile source of marine natural products with biomedical applications [10–12].

The first successful sponge-derived pharmaceutical drugs were the nucleosides spongothymidine and spongouridine which were isolated from Tectitethya crypta (formerly Cryptotethya crypta) [13,14]. A derivative of these nucleosides, Ara-C (also known as 1-beta-d-Arabinofuranosylcytosine or cytarabine) is documented as the first marine derived anticancer agent [15] that is currently used for the treatment of leukemia [16]. Ara-C is also screened in several clinical trials for the treatment of acute myeloid leukemia (AML) in combination with drugs such as Daunoribicin [17], Clofarabine [18] and Cladribine [19].

Despite the technological challenges in characterizing and scaling up production of bioactive compounds from marine sponges [20], several sponge-derived anticancer compounds are in preclinical/clinical trials [21–24]. Here, we review recently confirmed apoptosis-inducing anticancer lead compounds isolated from marine sponges which may have the potential to be future drug molecules. We used the National Center for Biotechnology Information (NCBI) PubMed database [25] to search for marine sponge derived anticancer compounds using the following keywords:

‘marine sponge’ AND (programmed cell death OR apoptosis OR antitumor* OR anti-tumor* OR anticancer* OR anti-cancer* OR antineoplasm* OR anti-neoplasm*)

This query was limited to articles published from 01/01/2005 to 31/01/2011, so as to include only recently confirmed apoptosis inducing lead compounds isolated from marine sponges. This yielded a total of 218 documents, curation of which allowed for the identification of 39 apoptosis-inducing lead compounds (Table 1) that have the potential to be developed as anticancer drugs.

2. Extensively Studied Apoptotic Pathways 2.1. The Death Receptor or “Extrinsic” Apoptosis Pathway of Type I and Type II

The extrinsic apoptosis signaling pathway is mediated by the activation of cell surface receptors (death receptors) that ligate with specific ligands to form a death inducing signaling complex (DISC) that transmits the apoptotic signals. Some DISC include CD95/Fas (CD95L/FasL) [54], TNFR1 (TNF) [55], DR3 (Apo3L) [56], DR4 (TRAIL-R1) [57] and DR5 (TRAIL-R2) [57]. The procaspase-8 is then sequestered by the DISC resulting in high local concentrations of zymogen. Under this condition, the low intrinsic protease activity of pro-caspase-8 is sufficient to allow various proenzyme molecules to mutually cleave and activate each other resulting in active caspase-8 [58]. Active caspase-8 then directly activates downstream effector caspase-3 resulting in the death of cells classified as type I cells (Figure 1) [59].

In type II cells, the above described signal requires amplification by the simultaneous activation of the mitochondria-dependent apoptotic pathway [59]. The mitochondria-dependent apoptotic pathway is activated when active caspase-8 additionally cleaves Bid to form the truncated Bid (tBid) which translocates to the mitochondria to induce outer membrane permeabilization whilst the inner membrane permeabilization that is promoted by the mitochondrial permeability transition pore formed across inner membranes when Ca²⁺ reaches a critical threshold [60,61]. Permeabilization of the membrane leads to the release of apoptogenic factors including cytochrome c [62], apoptosis-inducing factor (AIF) [63], second mitochondria-derived activator of caspases (Smac/Diablo) [64], EndoG [65] and HtrA2/Omi [66]. Cytochrome c and Smac/DIABLO activates the caspase dependent pathway. The cytochrome c disrupts the binding between Bcl-2 and pro-apoptotic protease activating factor (Apaf-1). The unbound Apaf-1 binds to procaspase-9 form the Apaf-1/caspase-9 complex that together with ATP and cytochrome c forms the apoptosome [67]. The apoptosome activates caspase-3 and -7 [68]. Caspase-3 successively mediated cleavage of (1) inhibitor caspase-activated deoxyribonuclease IFN (ICAD) resulting in the release and activation of the catalytic subunit CAD which is responsible for the fragmentation of the DNA into approximately 200 bp fragments [69], and (2) poly (ADP-ribose) polymerase (PARP) [70] and caspase-6 [71]; thus impeding the DNA repair mechanism, and bringing forth lamin protein degradation along with the disturbance of the fodrin and gelsolin matrix respectively [72,73]. Smac/DIABLO aids the caspases in dismantling of the cell by binding to and deactivating the inhibitor of apoptosis proteins (IAPs), thus preventing the IAPs from arresting the apoptotic process [74]. The other apoptogenic factors such as AIF and Endo G promotes DNA fragmentation in a caspase-independent manner to execute cell death [65,75]. AIF additionally induces the negatively charged phosphatidylserine to externalize on the cell membrane [76]. HtrA2/Omi is a Smac/DIABLO-like inhibitor of IAP activity that acts in a caspase-independent manner to execute cell death [66]. As a consequence of the above sequence of events, apoptotic cells display characteristic morphology changes such as cellular shrinking, chromatin condensation and margination at the nuclear periphery which ultimately results in membrane-bound apoptotic vesicles that are phagocytosed without triggering inflammatory responses that are distinct from that seen with necrotic cells [77].

2.2. The Mitochondrial or “Intrinsic” Apoptosis Pathway

The mitochondrial pathway can be activated by a variety of receptor-independent stimuli such as radiation, chemotherapeutics, hypoxia, ROS, Bax, p53 and viral infections [78]. Exposure to radiation or chemotherapeutics induces DNA damage that leads to the activation of p53 [79]. Activated p53 initiated the expression of (1) p21 that binds to the cyclin/kinase complex giving rise to a cell cycle restriction site in which an attempt is made to repair the DNA, and (2) GADD + PCNA that attempts to repair the DNA damage. If the DNA damage is irreparable p53 further initiated the expression of the Bax [80]. The increased levels of Bax increase the concentrations of Bax/Bax complexes (proapoptotic complex) that have been demonstrated to displace the Bcl-2/Bax complexes (anti-apoptotic complex) that compete for the same receptor site on the mitochondrial membrane [81]. The binding of the Bax/Bax complex to the mitochondrial membrane brings forth the release of the apoptogenic factors that signifies the point where the intrinsic and extrinsic pathways converge (refer to Figure 1).

3. Apoptosis-Inducing Lead Compounds

An overview of the 39 apoptosis-inducing lead compounds from marine sponge reported in literature since 01/01/2005, based on their putative biogenetic origin is presented in Figure 2. The compounds identified comprised 14 alkaloids, 13 terpenoids, 7 lipids and 5 macrolides. The disproportionately high frequency of alkaloids and terpenoids was also observed by Blunt et al. (2008) [82].

3.1. Alkaloids 3.1.1. Renieramycin M

Renieramycins are members of the tetrahydroisoquinoline family that were isolated from marine sponges belonging to genera Reniera [83], Xestospongia [84,85], Cribrochalina [86] and Neopetrosia [87]. A recent study by Halim et al. demonstrated that Renieramycin M (Figure 3) isolated from the Xestospongia species induced apoptosis via the p53-dependent pathway and inhibits the progression and metastasis of non-small lung cancer cells [32]. Other members of this family such as Renieramycin G and its analog 3-epi-renieramycin G, both of which possess an amide carbonyl group at the C-21 position demonstrated minimal antiproliferative activity in human colorectal cancer (HCT-116) and human lung adenocarcinoma (A549) cells owing to both compounds possessing an amide carbonyl group at the C-21 position [88]. The minimal antiproliferative activity for members of the tetrahydroisoquinoline family possessing an amide carbonyl group at the C-21 position seems consistent compared to their C-21 cyano- or carbinolamine-containing relatives [89].

3.1.2. Naamidine A

Copp et al. isolated Naamidine A (Figure 4) from the Fijian marine sponge Leucetta chagosensis and demonstrated that the compound inhibits the EGF signaling pathway and is more specific for the EGF-mediated mitogenic response than for the insulin-mediated mitogenic response [90]. In 2009, LaBarbera et al. demonstrated that Naamidine A induces biomarkers of apoptosis such as externalization of phosphatidylserine, disruption of the mitochondrial membrane potential, and cleavage and activation of caspases-3, -8, and -9, suggesting that the cell death induced by Naamidine A in epidermoid carcinoma (A-431) cells is a result of apoptosis rather than cytotoxicity [30]. Naamidine A was also shown to inhibit tumour xenograft growth via activation of caspase-3 suggesting apoptosis activity in vivo. Furthermore, Naamidine A-induced apoptosis is independent of extracellular signal-regulated kinase 1/2 and does not require functional p53 [30].

3.1.3. Psammaplysene A

Schroeder et al. (2005) isolated Psammaplysene A and B (Figure 5) from the Indian Ocean marine sponge, Psammaplysilla sp. when screening for specific inhibitors of nuclear export of the transcription factor FOXO1a [91]. Schroeder et al. demonstrated that both Psammaplysene A and B were active inhibitors of FOXO1 nuclear export but Psammaplysene A was the more potent inhibitor [91]. Berry et al. further demonstrated that human endometrial cancer (Ishikawa and ECC-1) cells treated for 24 h with 1 μM Psammaplysene A induces cell death displaying morphology changes consistent with apoptosis and PARP cleavage, suggesting that the cell death induced by Psammaplysene A is a consequence of apoptosis rather than cytotoxicity. Psammaplysene A was also shown to induce the doubling of cells in the G2/M phase and FOXO1 silencing in ECC-1 cells lessens Psammaplysene A-induced apoptosis [31].

3.1.4. Monanchocidin

Monanchocidin (Figure 6) is a novel polycyclic guanidine alkaloid isolated from the marine sponge Monanchora pulchra [29]. Guzii et al. demonstrated that Monanchocidin induces cell death in human monocytic leukemia (THP-1), human cervical cancer (HeLa) and mouse epidermal (JB6 Cl41) cells. Additionally, they demonstrated that THP-1 cells treated for 12 h with 1 μM Monanchocidin induces externalization of phosphatidylserine, suggesting that cell death induced by Monanchocidin may be a consequence of apoptotic as opposed to necrotic cell death [29].

3.1.5. Kuanoniamines A and C

Kuanoniamines A and C (Figure 7), pyridoacridine alkaloids isolated from the Thai marine sponge Oceanapia sagittaria were shown to be growth inhibitors of breast adenocarcinoma (estrogen-dependent ER (+)) (MCF-7), breast adenocarcinoma (estrogen-independent ER (−)) (MDA-MB-231), non-small cell lung cancer (NCI-H460), diploid embryonic lung fibroblast (MRC-5), glioblastoma (SF-268) and melanoma (UACC-62) cells [27]. Kuanoniamine C was less potent but showed high selectivity toward the estrogen dependent (ER+) MCF-7 cells. It was further demonstrated that Kuanoniamine A is a more potent inhibitor of DNA synthesis than Kuanoniamine C, and Kuanoniamine A was shown to cause an extensive reduction of the MCF-7 cells in the G2/M phase. It was also demonstrated that MCF-7 cells treated for 24 h with Kuanoniamine A (0.5 and 1 μM) and Kuanoniamine C (1 and 2.5 μM) respectively, displayed DNA fragmentation consistent with apoptosis [27]. Interestingly, in 1994, MacDonald et al. isolated the congeners Dehydrokuanoniamine B and Kuanoniamine D from the Fijian Cystodytes sp. ascidian and demonstrated that these compounds inhibit TOPO II-mediated decatenation of kinetoplast DNA correlated with their cytotoxic potencies and their ability to intercalate into calf thymus DNA [92]. Taken together, Kuanoniamines A and C likely inhibit DNA synthesis via the same mechanism as Dehydrokuanoniamine B and Kuanoniamine D.

3.2. Terpenoids 3.2.1. Rhabdastrellic Acid-A

In 1997, Rao et al. isolated Rhabdastrellic acid-A (Figure 8), a novel triterpenoid from the marine sponge Rhabdastrella globostellata. Ten years later, Guo et al. demonstrated that human promyelocytic leukemia (HL-60) cells treated for 36 h with 1 μM Rhabdastrellic acid-A induces condensation of nuclear chromatin and DNA fragmentation. Rhabdastrellic acid-A was also shown to induce other hallmarks of apoptosis such as PARP cleavage and caspase-3 activation [51]. They additionally demonstrated that mRNA levels of 44 genes, including p73, JunD, TNFAIP3 and GADD45A, were up-regulated whilst the mRNA levels of 16 genes, including MAP2K5 and IGF2R, were down-regulated [50]. Li et al. demonstrated that Rhabdastrellic acid-A also induces caspase-independent autophagy-associated cell death through blocking the Akt pathway in heptocellular carcinoma (Hep3B) and A549 cells [93].

Li et al. further isolated nine new isomalabaricane-derived natural products, Globostelletins A–I from the marine sponge Rhabdastrella globostellata, together with Jaspolides F, Rhabdastrellic acid-A, (−)-Stellettin E, Stellettins C and D [94]. They demonstrated that all the compounds induced inhibitory activities in A549, human gastric gland carcinoma (BGC-823), human intestinal adenocarcinoma (HCT-8) and human hepatocellular carcinoma (Bel-7402) cells and confirmed that HL-60 cells treated for 24 h with 5 μM Rhabdastrellic acid-A induces externalization of phosphatidylserine characteristic of apoptotic cell death [94].

3.2.2. Stellettin A and B, and Geoditin A and B

Zhang and Che isolated four isomalabaricane triterpenes (Stellettin A, Stellettin B, Geoditin A and Geoditin B) (Figure 9) from marine sponge Geodia japonica [95]. Liu et al. demonstrated that Stellettin A, Stellettin B, Geoditin A and Geoditin B induce cytotoxicity in HL-60 cells with Geoditin A being the most potent, followed by Stellettin A and B while Geoditin B showed the least potency. Liu et al. further demonstrated that HL-60 cells treated for 24 h with 3 μM of all four compounds respectively, induced dissipation of mitochondrial membrane potential, activation of caspase-3, and a decrease in levels of proliferating cell nuclear antigen (PCNA) characteristic of apoptotic cell death [46]. It was also demonstrated that apoptosis induced by Geoditin A displayed a dose-dependent increase of reactive oxygen species (ROS) and an increase in externalization of phosphotydilserine [46].

3.2.3. Jaspolide B

Jaspolide B (Figure 10), a novel isomalabaricane-type triterpene was isolated from the sponge Jaspis sp. [50,96]. Wei et al. demonstrated that Bel-7402 and human hepatocellular liver carcinoma (HepG2) cells treated for 24 h with 20 μM Jaspolide B induces increased mitochondrial masses and cell membrane permeability, as well as nuclear condensation characteristic of apoptotic cell death. Jaspolide B was also shown to induce cell cycle arrest in the G₁ phase in both Bel-7402 and HepG2 cells [50]. Moreover, Jaspolide B induced disassembly of the microtubule cytoskeleton in Bel-7402 cells, the effect of which being similar but weaker than that of the known microtubule-disassembly agent, colchicines [50].

3.2.4. Smenospongine

Kondracki and Guyot were the first to isolate Smenospongine (Figure 11) from the Smenospongia sp. as early as 1987 and demonstrated that Smenospongine induces cytotoxic and antimicrobial activity [97]. Later, Aoki et al. isolated Smenospongine from the Indonesian marine sponge Dactylospongia elegans [44,98]. It was demonstrated that Smenospongine induced the differentiation of human erythromyeloblastoid leukaemia (K562) cells into erythroblasts, cell-cycle arrest in the G1 phase and increased expression of p21 [98]. In addition, human leukemic monocyte lymphoma (U937) cells treated for 24 h with 15 μM Smenospongine induced DNA fragmentation characteristic of apoptotic cell death [53]. Kong et al. further demonstrated that smenospongine-induces antiproliferative and antiangiogenic activities such as endothelial migration and tube formation of human umbilical vein endothelial cells (HUVECs) [99].

3.2.5. 13<italic>E</italic>,17<italic>E</italic>-Globostellatic Acid X Methyl Ester

Aoki et al. isolated seven new compounds (13Z,17Z-globostellatic acid X methyl ester, 13Z,17E-globostellatic acid X methyl ester, 13E,17Z-globostellatic acid X methyl ester, and 13E,17E-globostellatic acid X methyl ester (Figure 12), Acetyljaspiferal E, Globostellatic acid F methyl ester and 13E-globostellatic acid B methyl ester) from the marine sponge Rhabdastrella globostellata, as selective anti-proliferative agents of HUVECs [44]. They demonstrated that HUVECs treated for 48 h with 1 μM 13E,17E-Globostellatic acid X methyl ester induces caspase-3 and -7 activity, suggesting that 13E,17E-globostellatic acid X methyl induced cell death may be a consequence of apoptosis [44]. Aoki et al. further demonstrated that 13E,17E-Globostellatic acid X methyl ester also induces antiangiogenic activities such as endothelial migration and tube formation of HUVECs [44].

3.3. Lipids 3.3.1. Petrosterol-3,6-dione and 5α,6α-<italic>epoxy</italic>-Petrosterol

Nguyen et al. isolated two new C₂₉ sterols, Petrosterol-3,6-dione and 5α,6α-epoxy-petrosterol (Figure 13) along with the known C₂₉ sterol, Petrosterol from the Vietnamese marine sponge Ianthella sp. [35]. It was shown that all three compounds induced cell death in A549, HL-60, U937, MCF-7 and human ovarian carcinoma (SK-OV-3) cells. To further evaluate whether this cell death was necrotic or apoptotic, the HL-60 cells were treated for 24 h with IC₅₀ (19.9, 21.3, and 21.5 μM) of each compound (Petrosterol-3,6-dione, 5α,6α-epoxy-petrosterol and Petrosterol) respectively. Each compound induced apoptotic events such as chromatin condensation and DNA fragmentation with Petrosterol being the more potent apoptosis inducer [35]. Since the compounds induced apoptotic cell death in HL-60 cells, it is expected to be able to induce apoptotic cell death in the other cells tested but which compound will be the most potent in the other cell lines and the mechanisms of cell death induced by these compounds based on cancer cell types remains unresolved.

3.3.2. Pachastrissamine

Kuroda et al. originally isolated the anhydrophytosphingosine, Pachastrissamine (also known as Jaspine B) (Figure 14) from the marine sponge Pachatrissa sp. and demonstrated that Pachatrissamine induced cytotoxicity in mouse lymphocytic leukemia (P388), A-549, human colon adenocarcinoma (HT-29) and human melanoma (SK-Mel-28) cells [100]. Salma et al. further demonstrated that B16 mouse melanoma cells induced for 6 h with 5 μM Pachastrissamine trigger hallmarks of apoptosis such as externalization of phosphatidylserine, release of cytochrome c, PARP cleavage and activation of caspase-3 and -9. Moreover, they demonstrated that Pachastrissamine inhibited the activity of sphingomyelin synthase (SMS), an enzyme that converts ceramide into the membrane lipid sphingomyelin. To evaluate whether this inhibitory activity played a role in the Pachastrissamine-induced cell death mechanism, they further demonstrated that cell death was enhanced in SMS1-depleted cells, whilst it was strongly inhibited in cells that stably overexpress human SMS1 [37]. Taken together, ceramide formation plays a key role in activating the mitochondrial-dependent pathway induced by Pachastrissamine.

3.3.3. Rhizochalin

Rhizochalin (Figure 15) is a two-headed sphingolipid isolated from the Madagascarian sponge Rhizochalin incrustata [101]. Jin et al. demonstrated that HL-60 cells induces for 24 h with 10 μM Rhizochalin display hallmarks of apoptosis such as disruption of the mitochondrial membrane potential, cleavage of PARP and activation of caspase-3, -8 and -9 in HL-60 cells [102]. The activation of caspase-8 suggests that this two-headed sphingolipid induces a death receptor pathway.

3.4. Macrolides 3.4.1. Salarin C

Ben-Califa et al. isolated Salarin A–J from the marine sponge Madagascar Fascaplysinopsis sp. and demonstrated that Salarin C (Figure 16) is the most potent proliferation inhibitor of K562 cells [42]. It was further shown that K562 cells induced for 24 h with 0.1 μM Salarin C-displayed numerous hallmarks of apoptosis such as externalization of phosphotydilserine, cleavage of PARP and activation of caspase-3 and -9 [42].

3.4.2. Spongistatin 1

The macrocyclic lactone polyether Spongistatin 1 (Figure 17) was isolated as early as 1993 from the marine sponge Spongia sp. [103,104]. Spongistatin 1 was shown to inhibit mitosis, microtubule assembly, and the binding of vinblastine to tubulin thereby inducing cytotoxic cell death in numerous cancer cell lines [104]. Fifteen years later, Schyschka et al. demonstrated that Spongistatin 1-induced human acute leukemia (Jurkat T) cells displayed hallmarks of apoptosis such as mitochondrial-released of cytochrome c, Smac/DIABLO and Omi/HtrA2 and caspase activation [43]. The activation of caspase-9 and suppression of Spongistatin 1-induced apoptosis by overexpressed Bcl-2 and Bcl-xL indicates that Spongistatin 1-induces apoptosis through the mitochondrial pathway. Moreover, Spongistatin 1 was shown to degrade XIAPs and induce cell death in leukemic tumor cells that are known to be resistant to apoptosis induction due to the overexpression of XIAPs [43].

Schneiders et al. additionally demonstrated that MCF-7 cells treated for 8 h with 500 pM Spongistatin 1 displayed activation of Bim and by 16 h Bim had mediated the translocation of AIP and endo G from the mitochondria. They further used gene silencing to confirm that the Spongistatin 1-induced apoptosis is primarily via a caspase-independent signaling pathway [105] Rothmeier et al. further demonstrated that Spongistatin 1 is a microtubule-depolarizing compound that induces endothelial migration, tube formation, G2/M arrest, and induction of apoptosis at roughly the same inhibitory concentration (1 nM) [106]. Spongistatin 1 was demonstrated to be a more potent inhibitor of angiogenesis than Vinblastine, CA4P, and Paclitaxel, as Spongistatin 1-induced proliferation 100 pM, migration 1.0 nM, tube formation 1.0 nM, chemotaxis 1.0 nM and aortic ring sprouting 500 pM.

3.4.3. Candidaspongiolide

Meragelman et al. isolated Candidaspongiolide (Figure 18) from the marine sponge Candidaspongia sp. and demonstrated that this compound induced potent cytotoxicity in melanoma and glioma cells [107]. Trisciuoglio et al. further demonstrated that HCT-116 and human glioblastoma (U251) cells treated for 24 h with 50 μM Candidaspongiolide induced hallmarks of apoptosis such as cleavage of PARP and activation of caspase-3 and -12. They further demonstrated that Candidaspongiolide induced a non-classic PKR/eIF2alpha/caspase-12-dependent apoptotic pathway and inhibited protein synthesis in HCT-116 and U251 cells [39]. While in normal fibroblasts Candidaspongiolide only inhibited protein synthesis [39].

3.4.4. Irciniastatin A

Irciniastatin A (also known as Psymberin) (Figure 19) was isolated by Pettit et al. from the marine sponge Ircinia ramose [108], and by Cichewicz et al. from the marine sponge Psammocinia sp. [107]. Cichewicz et al. demonstrated that Irciniastatin A induced cytotoxicity in human lung melanoma (MALME-3M), human skin melanoma (SK-MEL-5), p53 wild-type human melanoma (UACC-62), HCT-116 and human breast adenocarcinoma (MDA-MB-435) cells [109]. Chinen et al. further demonstrated that Jurkat T cells treated for 3 h with 10 nM Irciniastatin A induced hallmarks of apoptosis such as capase-8, -9 and -3, suggesting that Irciniastatin A induces a death receptor pathway [40].

4. Discussion

Because of the pressing need to develop non-cytotoxic anticancer treatments, novel apoptosis-inducing drug leads that have the potential to be developed into effective targeted cancer therapies are of interest to the cancer research community. In this regard, marine sponge-derived bioactive metabolites continue to be one of the most promising sources of new drug leads. The Blunt et al. yearly reviews of literature published for marine natural products covered 5666 novel compounds isolated from 2002 to 2008, with approximately one third of these compounds being isolated from marine sponge [82,110–115]. Many of these sponge-derived novel compounds have been screened for cytotoxic activity, but not apoptosis [116–118].

Cytotoxic activity is regarded as the first indicator in identifying anticancer drugs [119]. However, increasing evidence has shown that cell death can be induced via three different mechanisms: apoptosis (programmed cell death type I), autophagy (programmed cell death type II, or lysosomal cell death), and oncosis (programmed cell death type III, also referred to as necrosis) [120]. Cell death by autophagy is characterized by: (a) being mainly caspase-independent; (b) organelles degrading at an early stage of cell death; (c) the cytoskeleton remaining preserved until the final phase of the dying process; and (d) the formation of autophagosomes that fuse together with lysosomes which degrade the autophagosomes content [120]. Marine sponge derived cytotoxic compounds such as the aminosteroid clionamine A [121], the alkaloid xestospongin B [122] and the triterpenoid rhabdastrellic acid-A [93] were shown to induce cell death by autophagy. Oncosis is characterized by: (a) cellular swelling; and (b) cell membrane bursting that releases the cellular contents into the environment causing inflammatory cell suicide [120]. In contrast with autophagy and oncosis, apoptosis is the natural cell death mechanism that is characterized by: (a) chromatin condensation; (b) nuclear fragmentation and chromosomal DNA fragmentation (karyorrhexis); (c) alterations of the cellular membrane; (d) cellular shrinkage; and (e) the formation of vesicles that are phagocytosed by macrophages leading to non-inflammatory cell suicide [120]. The mechanisms through which lead compounds induce apoptosis remains debatable; however, cell death via apoptosis induction is widely accepted as an effective strategy for the identification of potential anticancer drugs.

The efficacy of treatment with apoptotic drugs is however limited by their toxicity to normal cells [123]. One of the recently confirmed apoptosis-inducing lead compounds isolated from marine sponges, Candidaspongiolide was shown to induce a PKR/eIF2alpha/caspase 12-dependent apoptotic pathway in HCT-116 and U251 cells, but not in normal fibroblasts [39].

The apoptotic pathway induced and the structure of the apoptosis-inducing lead compound allow for the targeting of selective cancer types. Irciniastatin A in particular, was shown to induce selective cell killing against melanoma (MALME-3M, SK-MEL-5 and UACC-62), colon (HCT-116) and breast (MDA-MB-435) cancer cells [109]. Also, the similarly structured Kuanoniamines A and C induced selective cell killing against breast (MCF-7 and MDA-MB-231), lung (NCI-H460 and MRC-5), glioblastoma (SF-268) and melanoma (UACC-62) cancer cells [27], with Kuanoniamine C inducing less potent cell death than Kuanoniamines A but displaying high selectivity toward the estrogen dependent (ER+) breast (MCF-7) cancer cells [27]. It was also shown that a caspase-dependent apoptotic pathway is induced in the HL-60 cells by the similarly structured isomalabaricane triterpenes (Stellettin A, Stellettin B, Geoditin A and Geoditin B) [46]. Apoptosis-induction varies among these four isomalabaricane triperpenes, with Geoditin A being the most effective inducer, followed by Stellettin A, Stellettin B and Geoditin B, respectively [46]. However, it remains unclear whether there is a difference in the apoptosis pathways and the potency of apoptosis induced by the isomalabaricane triperpenes, and which compound type is a more suitable candidate lead compound to be developed into an anticancer drug that targets leukemia.

Other compounds such as Rhabdastrellic acid-A has been shown to induce different types of cell death, as it was demonstrated that Rhabdastrellic acid-A induced caspase-dependent apoptosis in HL-60 cells [51], but to the contrary, induces caspase-independent autophagy-associated cell death through blocking the Akt pathway in Hep3B and A549 cells [93].

Having an understanding of the apoptotic mechanism induced by the lead compound and the advantages and the limitations of the compound structure on different cancer types will increase the lead compounds chances of developing into a recognized targeted cancer therapy. Furthermore, if it were only a matter of bioactivity, or having a unique pharmacological profile, hundreds of sponge-derived compounds would enter drug development in the pharmaceutical industry. However, other factors besides bioactivity such as a cost-effective source of large-scale supply, and drug ability will determine whether the lead compound enters the drug development pipeline [20]. Sponge-derived compounds that are currently in clinical trials were all found to be amenable to cost-effective chemical synthesis, thus solving the supply question early-on in the development continuum [124–126]. Thus far, the chemical synthesis of the apoptosis-inducing lead compounds listed in Table 1 include Renieramycin M [127], Naamidine A [128], Psammaplysenes A and B [129], 13E,17E-globostellatic acid X methyl ester [130], Pachastrissamine [131,132], Spongistatin 1 [133,134] and Irciniastatin A [135,136].

5. Conclusions

This review highlights recently confirmed apoptosis-inducing compounds isolated from marine sponge that have the potential to be developed into targeted cancer therapies. There are numerous cytotoxic metabolites that have been isolated from marine sponge but have not been screened for apoptosis activity. Moreover, the effects of the apoptosis-inducing compounds on the apoptotic signaling pathways have been summarized, even though most of these compounds have not yet been studied in depth for their mechanisms of action. Further research needs to be focused on clarifying the apoptotic pathways induced by the potential anticancer drugs to help singling out those that are the most promising for development of new anticancer drugs.

References 1

Kawabe

G2 checkpoint abrogators as anticancer drugs

Mol. Cancer Ther20043513519

15078995

Maione

Rossi

Airoma

Ferrara

Castaldo

Gridelli

The role of targeted therapy in non-small cell lung cancer

Crit. Rev. Oncol. Hematol2004512944

10.1016/j.critrevonc.2004.02.002

15207252

Rossi

Gaidano

Messengers of cell death: apoptotic signaling in health and disease

Haematologica200388212218

12604411

Belarbi el

Contreras Gomez

Chisti

Garcia Camacho

Molina Grima

Producing drugs from marine sponges

Biotechnol. Adv200321585598

14516872

Wehrl

Steinert

Hentschel

Bacterial uptake by the marine sponge Aplysina aerophoba

Microb. Ecol200753355365

10.1007/s00248-006-9090-4

17265004

Vacelet

Duport

Prey capture and digestion in the carnivorous sponge Asbestopluma hypogea (Porifera: Demospongiae)

Zoomorphology2004123179190

10.1007/s00435-004-0100-0

Sokolover

Ilan

Assessing anti-predatory chemical defences among ten eastern Mediterranean sponges

J. Mar. Biol. Assoc. UK20078717851790 8

Peters

Amsler

McClintock

Baker

Potential chemical defenses of Antarctic sponges against sympatric microorganisms

Polar Biolol201033649658

10.1007/s00300-009-0741-z

Chaves-Fonnegra

Castellanos

Zea

Duque

Rodriguez

Jimenez

Clionapyrrolidine A—a metabolite from the encrusting and excavating sponge Cliona tenuis that kills coral tissue upon contact

J. Chem. Ecol20083415651574

10.1007/s10886-008-9565-5

19023625

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep201128196268

10.1039/c005001f

21152619

Joseph

Sujatha

Pharmacologically Important Natural products from Marine Sponges

J. Nat. Prod20114512 12

Thomas

Kavlekar

LokaBharathi

Marine drugs from sponge-microbe association—a review

Mar. Drugs2010814171468

10.3390/md8041417

20479984

Bergmann

Feeney

The isolation of a new thymine pentoside from sponges

J. Am. Chem. Soc19507228092810 14

Bergmann

Feeney

Contributions to the study of marine products. XXXII. The nucleosides of sponges. I

J. Org. Chem195116981987

10.1021/jo01146a023

Proksch

Edrada

Ebel

Drugs from the seas—current status and microbiological implications

Appl. Microbiol. Biotechnol200259125134

10.1007/s00253-002-1006-8

12111137

Schwartsmann

Marine organisms and other novel natural sources of new cancer drugs

Ann. Oncol200011Suppl 3235243

11079147

Feldman

Lancet

Kolitz

Ritchie

Roboz

List

Allen

Asatiani

Mayer

Swenson

Louie

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

J. Clin. Oncol201129979985

21282541

Agura

Cooper

Holmes

Vance

Berryman

Maisel

Saracino

Tadic-Ovcina

Fay

Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity

Oncologist201116197206

21273514

Walker

Komrokji

Ifthikharuddin

Messina

Mulford

Becker

Friedberg

Oliva

Phillips

Liesveld

Abboud

Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML

Leuk. Res20083218301836

18571721

Sipkema

Osinga

Schatton

Mendola

Tramper

Wijffels

Large-scale production of pharmaceuticals by marine sponges: sea, cell, or synthesis?

Biotechnol. Bioeng200590201222

15739169

Madajewicz

Zojwalla

Lucarelli

Hentschel

Giardelli

Schuck

Krivelevich

Wong

Vogelzang

Sharma

A phase I trial of E7974 administered on days 1 and 15 of a 28-day cycle in patients with solid malignancies

J. Clin. Oncol2007252550 22

Yanagimoto

Shiomi

Satoi

Mine

Toyokawa

Yamamoto

Tani

Yamada

Kwon

Komatsu

Itoh

Noguchi

A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients

Oncol. Rep201024795801

20664989

Twelves

Cortes

Vahdat

Wanders

Akerele

Kaufman

Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer

Clin. Breast Cancer201010160163

20299316

Newman

Cragg

Marine natural products and related compounds in clinical and advanced preclinical trials

J. Nat. Prod20046712161238

15332835

Sayers

Barrett

Benson

Bolton

Bryant

Canese

Chetvernin

Church

DiCuccio

Federhen

Database resources of the National Center for Biotechnology Information

Nucleic Acids Res201139D38D51

21097890

Shubina

Makarieva

Dyshlovoy

Fedorov

Dmitrenok

Stonik

Three new aaptamines from the marine sponge Aaptos sp. and their proapoptotic properties

Nat. Prod. Commun2010518811884

21299112

Kijjoa

Wattanadilok

Campos

Nascimento

Pinto

Herz

Anticancer activity evaluation of kuanoniamines A and C isolated from the marine sponge Oceanapia sagittaria, collected from the Gulf of Thailand

Mar. Drugs20075622

18463725

Whibley

Keyzers

Soper

Davies-Coleman

Samaai

Hendricks

Antiesophageal cancer activity from Southern African marine organisms

Ann. N. Y. Acad. Sci20051056405412

16387705

Guzii

Makarieva

Denisenko

Dmitrenok

Kuzmich

Dyshlovoy

Krasokhin

Stonik

Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra

Org. Lett20101242924295

20804151

LaBarbera

Modzelewska

Glazar

Gray

Kaur

Liu

Grossman

Harper

Kuwada

Moghal

Ireland

The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells

Anticancer Drugs200920425436

19369860

Berry

Hardt

Clardy

Lurain

Kim

Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1

Gynecol. Oncol2009112331336

19041124

Halim

Chunhacha

Suwanborirux

Chanvorachote

Anticancer and Antimetastatic Activities of Renieramycin M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non-small Cell Lung Cancer Cells

Anticancer Res201131193201

21273598

Aoki

Cho

Ono

Kuwano

Nakao

Kuwano

Nakagawa

Gao

Mayumi

Shibuya

Kobayashi

Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells

Anticancer Drugs200617269278

16520655

Park

Kim

Hong

Park

Kim

Bae

Jung

Choi

Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells

Chemotherapy200753160168

17356266

Tung

Van Minh

Van Kiem

Huong

Dat

Nhiem

Tai

Hyun

Kang

Kim

C29 sterols with a cyclopropane ring at C-25 and 26 from the Vietnamese marine sponge Ianthella sp. and their anticancer properties

Bioorg. Med. Chem. Lett20091945844588

19615900

Umeyama

Matsuoka

Mine

Nakata

Arimoto

Matsui

Shoji

Arihara

Takei

Hashimoto

Polyacetylene diols with antiproliferative and driving Th1 polarization effects from the marine sponge Callyspongia sp

J. Nat. Med2010649397

19802655

Salma

Lafont

Therville

Carpentier

Bonnafe

Levade

Genisson

Andrieu-Abadie

The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism

Biochem. Pharmacol200978477485

19433071

Fedorov

Makarieva

Guzii

Shubina

Kwak

Stonik

Marine two-headed sphingolipid-like compound rhizochalin inhibits EGF-induced transformation of JB6 P⁺ Cl41 cells

Lipids200944777785

19579043

Trisciuoglio

Uranchimeg

Cardellina

Meragelman

Matsunaga

Fusetani

Del Bufalo

Shoemaker

Melillo

Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide

J. Natl. Cancer Inst200810012331246

18728285

Chinen

Nagumo

Watanabe

Imaizumi

Shibuya

Kataoka

Kanoh

Iwabuchi

Usui

Irciniastatin A induces JNK activation that is involved in caspase-8-dependent apoptosis via the mitochondrial pathway

Toxicol. Lett2010199341346

20920557

Konishi

Kikuchi

Ochiai

Ikoma

Kubota

Ichikawa

Fujiwara

Okamoto

Sakakura

Sonoyama

Kokuba

Sasaki

Matsui

Otsuji

Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice

Anticancer Res20092920912097

19528469

Ben-Califa

Bishara

Kashman

Neumann

Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis

Invest New Drugs2010

10.1007/s10637-010-9521-4.

Schyschka

Rudy

Jeremias

Barth

Pettit

Vollmar

Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP

Leukemia20082217371745

18548102

Aoki

Sanagawa

Watanabe

Setiawan

Arai

Kobayashi

Novel isomarabarican triterpenes, exhibiting selective anti-proliferative activity against vascular endothelial cells, from marine sponge Rhabdastrella globostellata

Bioorg. Med. Chem20071548184828

17524651

Dai

Fishback

Zhou

Nagle

Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1 (HIF-1) activation in both breast and prostate tumor cells

J. Nat. Prod20066917151720

17190448

Liu

Che

Apoptotic activity of isomalabaricane triterpenes on human promyelocytic leukemia HL60 cells

Cancer Lett2005230102110

16253766

Cheung

Che

Liu

Wang

Liu

Geoditin A induces oxidative stress and apoptosis on human colon HT29 cells

Mar. Drugs201088090

20161972

Schumacher

Cerella

Eifes

Chateauvieux

Morceau

Jaspars

Dicato

Diederich

Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death

Biochem. Pharmacol201079610622

19814997

Chueh

Kung

Pan

Shen

Guh

Ilimaquinone, a marine sponge metabolite, displays anticancer activity via GADD153-mediated pathway

Eur. J. Pharmacol20075564554

17140562

Wei

Tang

Sun

Cui

Lin

Induction of apoptosis accompanying with G(1) phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene

Cancer Lett2008262114122

18191890

Guo

Zhou

Feng

Liu

Xiao

Deng

Zhu

Apoptosis of human leukemia HL-60 cells induced by rhabdastrellic acid-A and its mechanisms

Ai Zheng200726809814(in Chinese)

17697538

Shi

Jain

Kim

Peng

Abraham

Youssef

El Sayed

Ambudkar

Chen

Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells

Cancer Sci20079813731380

17640301

Kong

Aoki

Sowa

Sakai

Kobayashi

Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells

Mar. Drugs20086480488

19005580

Peter

Krammer

The CD95(APO-1/Fas) DISC and beyond

Cell Death Differ2003102635

12655293

Lin

Hsu

Chou

Chang

Liu

Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-alpha and p53 pathways

Eur. J. Pharmacol2011650120129

20951126

Singh

Aggarwal

Death domain receptors and their role in cell demise

J. Interferon Cytokine Res199818439450

9712359

Merino

Lalaoui

Morizot

Schneider

Solary

Micheau

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2

Mol. Cell. Biol20062670467055

16980609

Bodmer

Holler

Reynard

Vinciguerra

Schneider

Juo

Blenis

Tschopp

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

Nat. Cell Biol20002241243

10783243

Scaffidi

Fulda

Srinivasan

Friesen

Tomaselli

Debatin

Krammer

Peter

Two CD95 (APO-1/Fas) signaling pathways

EMBO J19981716751687

9501089

Belizario

Alves

Occhiucci

Garay-Malpartida

Sesso

A mechanistic view of mitochondrial death decision pores

Braz. J. Med. Biol. Res20074010111024

17665037

Luo

Budihardjo

Zou

Slaughter

Wang

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

Cell199894481490

9727491

Kluck

Bossy-Wetzel

Green

Newmeyer

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

Science199727511321136

9027315

Susin

Lorenzo

Zamzami

Marzo

Snow

Brothers

Mangion

Jacotot

Costantini

Loeffler

Molecular characterization of mitochondrial apoptosis-inducing factor

Nature1999397441446

9989411

Fang

Wang

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

Cell20001023342

10929711

Luo

Wang

Endonuclease G is an apoptotic DNase when released from mitochondria

Nature20014129599

11452314

Suzuki

Imai

Nakayama

Takahashi

Takio

Takahashi

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death

Mol. Cell20018613621

11583623

Acehan

Jiang

Morgan

Heuser

Wang

Akey

Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation

Mol Cell20029423432

11864614

Slee

Harte

Kluck

Wolf

Casiano

Newmeyer

Wang

Reed

Nicholson

Alnemri

Green

Martin

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

J. Cell Biol1999144281292

9922454

Sakahira

Enari

Nagata

Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

Nature19983919699

9422513

Boulares

Yakovlev

Ivanova

Stoica

Wang

Iyer

Smulson

Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells

J. Biol. Chem19992742293222940

10438458

Hirata

Takahashi

Kobayashi

Yonehara

Sawai

Okazaki

Yamamoto

Sasada

Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis

J. Exp. Med1998187587600

9463409

Kothakota

Azuma

Reinhard

Klippel

Tang

Chu

McGarry

Kirschner

Koths

Kwiatkowski

Williams

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

Science1997278294298

9323209

Takahashi

Alnemri

Lazebnik

Fernandes-Alnemri

Litwack

Moir

Goldman

Poirier

Kaufmann

Earnshaw

Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis

Proc. Natl. Acad. Sci. USA19969383958400

8710882

Kumar

Shirley

Lewis

Role of genomics-based strategies in overcoming chemotherapeutic resistance

Curr. Pharm. Biotechnol20045471480

15544495

Joza

Susin

Daugas

Stanford

Cho

Sasaki

Elia

Cheng

Ravagnan

Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death

Nature2001410549554

11279485

Wang

Gengyo-Ando

Sun

Yang

Shi

Kobayashi

Shi

Mitani

Xie

Xue

C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1

Nat. Cell Biol20079541549

17401362

Studzinski

Overview of apoptosis

Apoptosis: A Practical ApproachOxford University Press

New York, NY, USA

19998 78

Indran

Tufo

Pervaiz

Brenner

Recent advances in apoptosis, mitochondria and drug resistance in cancer cells

Biochim. Biophys. Acta20111807735745

21453675

Chen

Gilkes

Pan

Lane

Chen

ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage

EMBO J20052434113422

16163388

Vogelstein

Lane

Levine

Surfing the p53 network

Nature2000408307310

11099028

Cheng

Kirsch

Clem

Ravi

Kastan

Bedi

Ueno

Hardwick

Conversion of Bcl-2 to a Bax-like death effector by caspases

Science199727819661968

9395403

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep2008253594

18250897

Frincke

Faulkner

Antimicrobial metabolites of the sponge Reniera sp

J. Am. Chem. Soc1981104265269 84

Davidson

Renieramycin G, a new alkaloid from the sponge Xestospongia caycedoi

Tetrahedron Lett19923337213724 85

Suwanborirux

Amnuoypol

Plubrukarn

Pummangura

Kubo

Tanaka

Saito

Chemistry of renieramycins. Part 3. Isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide

J. Nat. Prod20036614411446

14640515

Pettit

Knight

Collins

Herald

Pettit

Boyd

Young

Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species

J. Nat. Prod200063793798

10869203

Oku

Matsunaga

van Soest

Fusetani

Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp

J. Nat. Prod20036611361139

12932144

Lane

Estevez

Mortara

Callan

Spencer

Williams

Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G

Bioorg. Med. Chem. Lett20061631803183

16632360

Scott

Williams

Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics

Chem. Rev200210216691730

11996547

Copp

Fairchild

Cornell

Casazza

Robinson

Ireland

Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent

J. Med. Chem19984139093911

9748366

Schroeder

Kau

Silver

Clardy

The psammaplysenes, specific inhibitors of FOXO1a nuclear export

J. Nat. Prod200568574576

15844952

McDonald

Eldredge

Barrows

Ireland

Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: a mechanism for the apparent intercalator-induced inhibition of topoisomerase II

J. Med. Chem19943738193827

7525959

Guo

Huang

Wang

Deng

Liu

Feng

Xiao

Deng

Zhang

Zhu

Rhabdastrellic acid-A induced autophagy-associated cell death through blocking Akt pathway in human cancer cells

PLoS One20105e12176

20808909

Cui

Deng

de Voogd

Proksch

Lin

Globostelletins A–I, cytotoxic isomalabaricane derivatives from the marine sponge Rhabdastrella globostellata

Bioorg. Med. Chem20101846394647

20627740

Zhang

Che

Isomalabaricane-type nortriterpenoids and other constituents of the marine sponge Geodia japonica

J. Nat. Prod20016414891492

11754596

Tang

Pei

Deng

Proksch

Lin

Jaspolides A–F, six new isomalabricane-type terpenoids from the sponge Jaspis sp

Chem. Pharm. Bull. (Tokyo)20065448 97

Kondracki

Guyot

Smenospongine: a cytotoxic and antimicrobial aminoquinone isolated from smenospongia

Tetrahedron Lett19872758155818 98

Aoki

Kong

Matsui

Kobayashi

Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells

Anticancer Drugs200415363369

15057141

Kong

Yamori

Kobayashi

Duan

Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone

Mar. Drugs20119154161

21566792

100

Kuroda

Musman

Ohtani

Ichiba

Tanaka

Gravalos

Higa

Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp

J. Nat. Prod20026515051506

12398554

101

Makarieva

Denisenko

Stonik

Milgrom

Rashkes

Rhizochalin, a novel secondary metabolite of mixed biosynthesis from the sponge Rhizochalina incrustata

Tetrahedron Lett19893065816584 102

Jin

Shastina

Park

Han

Makarieva

Fedorov

Rasskazov

Stonik

Kwak

Differential induction of apoptosis of leukemic cells by rhizochalin, two headed sphingolipids from sponge and its derivatives

Biol. Pharm. Bull200932955962

19483298

103

Pettit

Cichacz

Gao

Herald

Boyd

Schmidt

Hooper

JNA

Isolation and Structure of Spongistatin-1

J. Org. Chem19935813021304 104

Bai

Cichacz

Herald

Pettit

Hamel

Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin

Mol. Pharmacol199344757766

8232226

105

Schneiders

Schyschka

Rudy

Vollmar

BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells

Mol. Cancer Ther2009829142925

19808980

106

Rothmeier

Schneiders

Wiedmann

Ischenko

Bruns

Rudy

Zahler

Vollmar

The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis

Int. J. Cancer201012710961105

20143389

107

Meragelman

Willis

Woldemichael

Heaton

Murphy

Snader

Newman

van Soest

Boyd

Cardellina

IIMcKee

Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia

J. Nat. Prod20077011331138

17564468

108

Pettit

Chapuis

Pettit

Tackett

Doubek

Hooper

Schmidt

Antineoplastic agents. 520. Isolation and structure of irciniastatins A and B from the Indo-Pacific marine sponge Ircinia ramosa

J. Med. Chem20044711491152

14971894

109

Cichewicz

Valeriote

Crews

Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family

Org. Lett2004619511954

15176791

110

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep2007243186

17268607

111

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep200421149

15039834

112

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep2005221561

15692616

113

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep2006232678

16453031

114

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep200926170244

19177222

115

Blunt

Copp

Munro

Northcote

Prinsep

Marine natural products

Nat. Prod. Rep201027165237

20111802

116

Bao

Sun

Yao

Hong

Lee

Cho

Jung

Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp

J. Nat. Prod20077028

17253840

117

Luo

Hong

Lee

Sim

Jung

Cytotoxic oxylipins from a marine sponge Topsentia sp

J. Nat. Prod200669567571

16643027

118

Mansoor

Lee

Hong

Lee

Jung

5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp

J. Nat. Prod200669131134

16441084

119

Zheng

Yan

Han

Chen

Lin

Lee

Wang

Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas piscicida and its apoptotic effect on cancer cells

Biotechnol. Appl. Biochem200644135142

16579793

120

Folmer

Jaspars

Dicato

Diederich

Marine cytotoxins: callers for the various dances of death

Gastroenterol. Hepatol. Bed Bench20092S34S50 121

Keyzers

Daoust

Davies-Coleman

Van Soest

Balgi

Donohue

Roberge

Andersen

Autophagy-modulating aminosteroids isolated from the sponge Cliona celata

Org. Lett20081029592962

18553912

122

Vicencio

Ortiz

Criollo

Jones

Kepp

Galluzzi

Joza

Vitale

Morselli

Tailler

Castedo

Maiuri

Molgo

Szabadkai

Lavandero

Kroemer

The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1

Cell Death Differ20091610061017

19325567

123

Andrews

Howell

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance

Cancer Cells199023543

2204382

124

Huang

Lopez-Barcons

Freeze

Smith

IIIGoldberg

Horwitz

McDaid

Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice

Clin. Cancer Res200612298304

16397055

125

Hadaschik

Adomat

Fazli

Fradet

Andersen

Gleave

Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin

Clin. Cancer Res20081415101518

18316576

126

Vahdat

Pruitt

Fabian

Rivera

Smith

Tan-Chiu

Wright

Tan

Dacosta

Chuang

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

J. Clin. Oncol20092729542961

19349550

127

Zhu

Asymmetric total syntheses of (−)-renieramycin M and G and (−)-jorumycin using aziridine as a lynchpin

Org. Lett20091155585561

19894720

128

Aberle

Lessene

Watson

A concise total synthesis of naamidine A

Org. Lett20068419421

16435849

129

Georgiades

Clardy

Total synthesis of psammaplysenes A and B, naturally occurring inhibitors of FOXO1a nuclear export

Org. Lett2005740914094

16146359

130

Kotoku

Tamada

Hayashi

Kobayashi

Synthesis of BC-ring model of globostellatic acid X methyl ester, an anti-angiogenic substance from marine sponge

Bioorg. Med. Chem. Lett20081835323535

18492609

131

Passiniemi

Koskinen

Asymmetric synthesis of Pachastrissamine (Jaspine B) and its diastereomers viaeta(3)-allylpalladium intermediates

Org. Biomol. Chem2011917741783

21264408

132

Bhaket

Morris

Stauffer

Datta

Total synthesis of cytotoxic anhydrophytosphingosine pachastrissamine (jaspine B)

Org. Lett20057875876

15727463

133

Crimmins

Katz

Washburn

Allwein

McAtee

Asymmetric total synthesis of spongistatins 1 and 2

J. Am. Chem. Soc200212456615663

12010038

134

Smith

IIIZhu

Shirakami

Sfouggatakis

Doughty

Bennett

Sakamoto

Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration

Org. Lett20035761764

12605509

135

Huang

Shao

Palani

Aslanian

Buevich

The total synthesis of psymberin

Org. Lett2007925972600

17523653

136

Jiang

Garcia-Fortanet

De Brabander

Synthesis and complete stereochemical assignment of psymberin/irciniastatin A

J. Am. Chem. Soc20051271125411255

16089449

Figures and Table Figure 1

Schematic illustration of the death receptor (type I and type II) and mitochondrial pathways.

Figure 2

Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge since the 01/01/2005, divided by putative biogenetic origin.

Figure 3

Structure of Renieramycin M.

Figure 4

Structure of Naamidine A.

Figure 5

Structure of Psammaplysene A.

Figure 6

Structure of Monanchocidin.

Figure 7

Structure of Kuanoniamines A (1) and C (2).

Figure 8

Structure of Rhabdastrellic acid-A.

Figure 9

Structure of Stellettin A (1) and B (2), and Geoditin A (3) and B (4).

Figure 10

Structure of Jaspolide B.

Figure 11

Structure of Smenospongine.

Figure 12

Structure of 13E,17E-globostellatic acid X methyl ester.

Figure 13

Structure of Petrosterol-3,6-dione (1) and 5α,6α-epoxy-petrosterol (2).

Figure 14

Structure of Pachastrissamine.

Figure 15

Structure of Rhizochalin.

Figure 16

Structure of Salarin C.

Figure 17

Structure of Spongistatin 1.

Figure 18

Structure of Candidaspongiolide.

Figure 19

Structure of Irciniastatin A.

Table 1

Recently confirmed apoptosis-inducing compounds isolated from marine sponges.

Compound	Type	Sponge	Cell line	Reference
(1) 2,3-dihydro-2,3-dioxoaaptamine	alkaloid	Aaptos sp.	THP-1	[26] (abstract)
(2) 3-(methylamino)demethyl (oxy)aaptamine	alkaloid	Aaptos sp.	THP-1	[26] (abstract)
(3) 6-(N-morpholinyl)-4,5-dihydro-5-oxo-demethyl (oxy)aaptamine	alkaloid	Aaptos sp.	THP-1	[26] (abstract)
(4) kuanoniamine A	alkaloid	Oceanapia sagittaria	MCF-7	[27]
(5) kuanoniamine C	alkaloid	Oceanapia sagittaria	MCF-7	[27]
(6) Makaluvic acid C	alkaloid	Strongylodesma aliwaliensis	WHC01WHC06KYSE30	[28]
(7) Monanchocidin	alkaloid	Monanchora pulchra	THP-1HeLa	[29]
(8) N-1-β-d-ribofuranosyl damirone C	alkaloid	Strongylodesma aliwaliensis	WHC01WHC06KYSE30	[28]
(9) N-1-β-d-ribofuranosyl makalu-vamine I	alkaloid	Strongylodesma aliwaliensis	WHC01WHC06KYSE30	[28]
(10) N-1-β-d-ribofuranosyl makaluvic acid C	alkaloid	Strongylodesma aliwaliensis	WHC01WHC06KYSE30	[28]
(11) Naamidine A	alkaloid	Leucetta chagosensis	A-431	[30]
(12) Psammaplysene A	alkaloid	Psammaplysilla	Ishikawa ECC1	[31]
(13) Renieramycin M	alkaloid	Xestospongia sp.	NSCLC	[32]
(14) Bastadin 6	alkaloid	lanthella sp.	HUVEC	[33] (abstract)
(15) (Z)-stellettic acid C	lipid	Stelletta sp.	U937	[34] (abstract)
(16) 5-alpha,6-alpha-epoxypetrosterol	lipid	Lanthella sp.	HL-60	[35]
(17) Callyspongidiol	lipid	Callyspongia sp.	HL-60	[36] (abstract)
(18) Jaspine B	lipid	Jaspis sp.	SK-Mel28	[37]
(19) Petrosterol	lipid	Lanthella sp.	HL-60	[35]
(20) Petrosterol-3,6-dione	lipid	Lanthella sp.	HL-60	[35]
(21) Rhizochalin	lipid	Rhizochalina incrustata	THP-1 HeLaSNU-C4	[38]
(22) Candidaspongiolide	macrolide	Candidaspongia sp.	U251HCT116	[39]
(23) Irciniastatin A	macrolide	Ircinia ramose	Jurkat T	[40]
(24) Latrunculins A and B	macrolide	Negombata magnifica	MKN45NUGC-4	[41] (abstract)
(25) Salarin C	macrolide	Fascaplysinopsis sp.	K562	[42]
(26) Spongistatin 1	macrolide	Spongia	Jurkat T	[43]
(27) 13E,17E-globostellatic acid X methyl ester	terpenoid	Rhabdastrella globostellata	HUVEC	[44]
(28) 3-epi-sodwanone K 3-acetate	terpenoid	Axinella sp.	T47D	[45]
(29) Geoditin A	terpenoid	Geodia japonica	HL-60HT29	[46][47]
(30) Geoditin B	terpenoid	Geodia japonica	HL-60	[46]
(31) Heteronemin	terpenoid	Hyrtios sp.	K562Jurkat T	[48]
(32) Ilimaquinone	terpenoid	Hippospongia metachromia	PC3	[49]
(33) Jaspolide B	terpenoid	Jaspis sp.	Bel-7402HepG2	[50]
(34) Rhabdastrellic acid-A	terpenoid	Rhabdastrella globostellata	HL-60	[51]
(35) Sipholenol A	terpenoid	Callyspongia siphonella	KB-3-1KB-C2KB-V1	[52]
(36) Smenospongine	terpenoid	Dactylospongia elegans	K56	[53]
(37) Sodwanone V	terpenoid	Axinella sp.	MDA-MB-231	[45]
(38) Stellettin A	terpenoid	Geodia japonica	HL-60	[46]
(39) Stellettin B	terpenoid	Geodia japonica	HL-60	[46]